The reactivity of SARS-CoV-2-specific T cells can be determined using a new CE-marked interferon-gamma release assay (IGRA) from EUROIMMUN – the Quan-T-Cell System. The Quan-T-Cell ELISA used in combination with the Quan-T-Cell SARS-CoV-2 enables fast, automatable and quantitative determination of the IFN-γ released by SARS-CoV-2-specific T cells.
The assay is performed on heparinised whole blood samples, circumventing the need to prepare purified peripheral mononuclear cells (PBMCs). In the test procedure, the T cells in the patient samples are stimulated using spike protein-based antigens in the provided tubes and the released IFN-γ is subsequently measured using a fully automated quantitative ELISA.
The IGRA supports detection of past contact with SARS-CoV-2 or detection of an immune response following vaccination against the virus. The Quan-T-Cell System is already well established in the research field and has been used for numerous published studies investigating immune responses in healthy individuals and in vulnerable groups such as immunocompromised persons, elderly persons or dialysis patients.
The Quan-T-Cell System complements EUROIMMUN’s extensive portfolio of COVID-19 diagnostic tests, which encompasses RT-PCR assays, diverse ELISAs, immunoblot, a dried blood spot sample collection set, as well as comprehensive automation options for all tests.
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png00panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2021-12-13 09:27:292023-12-15 10:22:23EUROIMMUN releases new assay for detection of SARS-CoV-2 reactive T cells
Regular colony counts are part of the day-to-day tasks of many laboratories in order to rule out the contamination of products with bacteria, viruses, yeasts, or moulds during production. To do this, Petri dishes containing the relevant samples are evaluated in order to determine the number of colonies formed. While the classic manual counting method means that every single colony has to be marked individually, automatic devices can analyse numerous Petri dishes of the same type very quickly. However, this requires time-consuming programming and preparation that may not be feasible if there is a small number of samples amounting to just a few Petri dishes a day.
The ColonyStar automatic from Funke-Gerber resolves this issue. The device, which is equipped with a camera and a cordless, detachable tablet, makes the analysis of Petri dishes both fast and straightforward. The unique assist mode is particularly helpful: After tapping on a colony via touchscreen, other colonies of the same type are automatically recorded, marked, and counted. The selection can be corrected at any time. In this way, the lab worker retains full control while also achieving huge time savings.
Total bacterial count
In hygiene management and quality control, the total bacterial count is one of the most important parameters. It states how many micro-organisms are contained within a sample. Depending on the type of micro-organism, there are limits that may not be exceeded in order to protect consumers from diseases such as food poisoning. As a result, samples are routinely cultured on Petri dishes in order to be able to determine the micro-organism concentration after a certain period via a colony count. Older devices in particular, however, that required the counting of every colony individually using a light table and microscope, made this task a time-consuming ordeal.
“A Petri dish like this, if it is processed at the right dilution, has between 150 and 200 colonies,” explains Konrad Schäfer, CEO of Funke-Dr. N. Gerber Labortechnik GmbH. “If they have to be counted manually, the person counting has to maintain their concentration and mark each colony individually. A routine task can quickly become a time-consuming endeavour.”
The previous method for colony counting also does not allow for the markings to be changed, which increases the risk of some colonies being counted twice. Automatic devices are more reliable but they are generally designed to handle larger batches and require a certain amount of effort to be invested beforehand.
“As a result of their complexity, such systems are a major financial investment. On the other hand, time-consuming preparations are necessary in order to program them because colony diameters or maximum/minimum contrast must be defined prior to automatic operation,” says Schäfer.
The ColonyStar automatic from Funke-Gerber, however, has been developed so that the device significantly accelerates manual counting with a semi-automatic counting mode. In order to mark 200 colonies, for example, only between four and 15 actions are necessary. The device operator retains complete control and does not have to rely solely on the device, as is the case with fully automatic solutions. In addition to this assist mode, the system can still be trained to identify selected colonies so that fully automatic colony counts can be conducted on predefined samples.
Additionally, the device features a fully automatic counting mode. The system can also be trained to recognize certain strains of bacteria and agar media. To do this, you can analyse ten to 15 Petri dishes containing the same species on the same agar media and then, after the learning phase, save it as a profile, such as Salmonella or yeast. Colonies of the same type that match these can then be analyzed fully automatically.
Biotium, a leading life science reagent supplier and inventor of the widely used ‘EvaGreen’ qPCR Dye, has released ‘EvaRuby’ Dye for qPCR and HRM. This spectrally unique red fluorescent intercalating dye can be incorporated into probe-based qPCR assays, expanding multiplexing options for probe-based qPCR. EvaRuby Dye is compatible with ~470 nm excitation and ~610 nm emission filters.
While a variety of DNA binding dyes with different fluorescence emission properties have been published for use in qPCR and HRM, only the green fluorescent dyes SYBR Green I, SYTO 9, and EvaGreen Dye have widespread use in these applications. EvaGreen Dye is currently the only dye suitable for qPCR and HRM in the same reaction, however, due to its relatively broad emission, EvaGreen cannot be combined with red PCR probes for multiplexing or HRM in probe qPCR reactions.
As a solution, Biotium scientists have developed EvaRuby, a unique dye with a much longer Stokes shift of 480/613 nm (excitation/emission). This allows excitation of EvaRuby Dye by the same green/blue channel as EvaGreen Dye, and detection in the orange (JUN or ROX) channel. As a result, EvaRuby Dye has minimal cross-talk in standard probe detection channels and enables the combination of dye-based and probe-based qPCR in a single reaction. In addition, EvaRuby Dye is validated for HRM analysis and may be used as an internal control for probe-based qPCR to detect non-specific amplification that goes undetected by target-specific probes. EvaRuby Dye is also suitable for singleplex qPCR, LAMP, and gel electrophoresis.
EvaRuby Dye has been validated on Applied Biosystems QuantStudio 5 96-well and Qiagen Rotor-Gene Q instruments, with potential compatibility for other qPCR instruments capable of acquiring data using ~470 nm excitation and ~610 nm emission filters.
Features and benefits of EvaRuby Dye include:
Spectrally Unique: Minimal cross-talk in neighboring channels
Flexible: Unique red dye that expands multiplexing capabilities for probe-based qPCR
Versatile: Can combine probe-based qPCR with HRM in the same reaction
Convenient: Easily confirm your results with melt curve analysis rather than time consuming post-qPCR gel electrophoresis
The release of EvaRuby Dye adds to Biotium’s industry-leading catalogue of qPCR reagents for life science research.
https://clinlabint.com/wp-content/uploads/sites/2/2021/12/biotium_evaruby.jpg1010870panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2021-12-13 09:19:372021-12-13 09:41:38Biotium introduces EvaRuby Dye for qPCR and HRM
Drawing upon over 30-years’ experience of serving the glycobiology research community, AMSBIO has established a comprehensive portfolio of high-quality reagents including unique ranges of antibodies, lectins, enzymes, assay kits and standards, backed by in-depth technical support.
Glycobiology (the study of the structure, biosynthesis, and biology of carbohydrates) is a complex and dynamic area of research that combines enzymology, molecular and cellular biology, organic chemistry and materials science. Widely acknowledged as critical for both cellular biology and studies of carbohydrate-based drugs and therapeutics, glycobiology is a rapidly expanding field of research that is attracting a lot of attention.
Dr William Hadlington-Booth, Glycobiology product manager commented: “To maintain our global reputation as the premier supplier for the glycobiology research community, we’re constantly introducing new leading-edge products as well as investing in inventory to help us supply researchers with key reagents when they need them.”
Working with leading research groups – AMSBIO has established an unmatched range of monoclonal antibodies and binding proteins for proteoglycan, glycosaminoglycan (GAG) and ganglioside research including Heparan Sulfate, Chondroitin Sulfate, Keratan Sulfate and Hyaluronic Acid. AMSBIO’s antibodies provide high levels of specificity and affinity to target antigens; and most glycobiology antibodies work across many model species.
AMSBIO also offers a comprehensive range of specialist enzymes for glycobiology research and other applications. The company’s glycosaminoglycan (GAG) degrading enzymes include chondroitinase, heparinase and hyaluronidase enzymes.
The enzymes heparanase and hyaluronidase both play essential roles degrading carbohydrates in the extracellular matrix; and chondroitinase ABC has been associated with promoting neural repair and plasticity. AMSBIO offers kits for measuring activity of these enzymes in cell culture supernatants, plasma and other biological fluids, and tissue samples. These kits have been widely used by leading research groups for studies on anti-inflammatory responses, kidney disease, and cancer as they solve the standardization and performance issues associated with traditional measurement techniques for these types of enzymes.
https://clinlabint.com/wp-content/uploads/sites/2/2021/12/amsbio303.jpg486409panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2021-12-13 09:15:492021-12-13 09:15:49AMSBIO offers advanced tools for glycobiology research
Alpha Laboratories has introduced the new Polyethylene glycol allergens from BÜHLMANN to the UK. These are for use with the FlowCAST basophil activation assay, providing a safer approach to determine those with a hypersensitivity reaction to PEG.
Allergy to Polyethylene glycol (PEG) is rare but can be severe. It is suspected to be the primary cause of allergic reactions in those individuals who have reacted adversely to COVID-19 vaccines. PEG is used as a stabiliser of lipid nanoparticles in the formulation of mRNA-based vaccines, thus allergy to it is increasingly being recognised.
Basophil activation testing (BAT) has been validated to support and investigate Polyethylene glycol (PEG) hypersensitivity reactions. BAT is performed on whole blood samples and offers a much safer, non-invasive alternative to allergy testing, compared with traditional in-vivo allergy tests, such as a skin prick test
PEGs at different molecular weights may result in different reactivity of patient basophils, so BÜHLMANN has produced several PEG allergens to maximise the chance of detecting an allergic response in a patient:
PEG 4000 – Linear PEG of molecular weight in the range of 3500-4500
PEG 2000 – Linear PEG of molecular weight in the range of 1900-2200
DMG PEG 2000 – Lipid component with a PEG 2000 chain
https://clinlabint.com/wp-content/uploads/sites/2/2021/12/PEG.png422424panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2021-12-13 09:12:172021-12-13 09:16:18Alpha Labs introduces to UK new PEG allergens for basophil activation assays
TRIMERO Diagnostics offers, under the brand KLoneus®, IVD CE marked nephelometric assays for testing FREE LIGHT CHAINS (FLC) on Beckman Coulter’s IMMAGE® Immunochemical Systems.
H.E.L Group, a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, has released the latest version of its laboratory automation software, labCONSOL 1.2. The new functionality included in the update further enhances the intuitive user experience to increase lab productivity and efficiency, and facilitate process automation.
Takara Bio Europe (TBE) has launched an in vitro diagnostic assay for the qualitative detection of novel coronavirus (SARS-CoV-2) from patients suspected of having Covid-19, based on real-time reverse transcriptase PCR (RT-qPCR). This CE-IVD kit complies with the Directive 98/79/EC on in vitro medical devices and is available for immediate distribution in selected countries.
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/Takara-Bio.png8721500panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2021-11-18 15:15:272021-11-18 15:15:27Takara Bio Europe’s CE-certified RT-qPCR diagnostic kit for SARS-CoV-2 gives result in 60 minutes
The EURORealTime SARS-CoV-2/Influenza A/B is a multiplex PCR-based test for fast and efficient detection and differentiation of SARSCoV- 2 and influenza viruses A and B from throat swabs. The assay aids discrimination between the clinically similar diseases COVID-19 and influenza, identification of potential co-infections and epidemiological surveillance.
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png00panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2021-11-18 15:11:432021-11-18 15:11:43EUROIMMUN releases combined PCR test for SARS-CoV-2 and influenza A/B
Cellbox Solutions is expanding its product portfolio: The Cellbox Solutions Packaging, which enables the best-in-class transport of living cell and tissue cultures, is now joined by the CBS Naturally-3D Kit. The innovative new product contains the CBS Transport Gel and the CBS Easy Release solution.
https://clinlabint.com/wp-content/uploads/sites/2/2021/11/Cellbox_Solutions.png6401280panglobalhttps://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.pngpanglobal2021-11-18 14:09:402021-11-18 14:09:40Cellbox Solutions introduces CBS Naturally-3D Kit in cooperation with UPM Biomedicals
We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.
Google Analytics Cookies
These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
Other external services
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.
Privacy Beleid
U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.